查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1714390

組學實驗室服務市場－全球產業規模、佔有率、趨勢、機會和預測，按服務、服務頻率、業務、最終用途、地區和競爭細分，2020-2030 年預測

Omics Lab Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Frequency Of Service, By Business, By End Use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球組學實驗室服務市場價值為 725.1 億美元，預計到 2030 年將達到 1,246.1 億美元，預測期內複合年成長率為 9.44%。這個快速發展的市場涵蓋基因組學、蛋白質組學、代謝組學、轉錄組學和表觀遺傳學，在理解複雜的生物系統方面發揮著至關重要的作用。這些服務支持疾病診斷、生物標記發現和精準治療開發。個人化醫療需求的不斷成長、高通量測序的進步以及組學在藥物研發、農業和環境科學等領域的應用日益廣泛，正在推動市場成長。隨著技術的發展，組學實驗室服務不斷擴大其在現代科學和醫療保健領域的應用和影響力。

市場概覽
預測期 2026-2030
2024年市場規模 725.1億美元
2030年市場規模 1246.1億美元
2025-2030 年複合年成長率 9.44%
成長最快的領域 癌症
最大的市場 北美洲

關鍵市場促進因素

基因組學數據日益融入臨床工作流程

主要市場挑戰

缺乏熟練的專業人員

主要市場趨勢

個人化醫療

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球組學實驗室服務市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按服務（基因組學、蛋白質組學、轉錄組學、代謝組學、表觀遺傳學）
    • 按服務頻率（一次性、重複、連續）
    • 按業務（醫院、研究機構、診斷實驗室）
    • 依最終用途（癌症、藥物、生殖、其他遺傳疾病）按地區
    • 按公司分類（2024）
    • 按地區
  • 市場地圖

第6章：北美組學實驗室服務市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲組學實驗室服務市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太組學實驗室服務市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 南
    • 澳洲

第9章：南美洲組學實驗室服務市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲組學實驗室服務市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品/服務的威脅

第 14 章：競爭格局

  • Agilent Technologies, Inc.
  • Q2 Solutions LLC
  • Flomics Biotech
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc
  • Quest Diagnostics Incorporated
  • Phenoswitch Bioscience
  • Spectrus Corporation
  • BEIJING GENOMICS INSTITUTE.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16260

The Global Omics Lab Services Market was valued at USD 72.51 billion in 2024 and is projected to reach USD 124.61 billion by 2030, growing at a CAGR of 9.44% during the forecast period. This rapidly advancing market spans genomics, proteomics, metabolomics, transcriptomics, and epigenetics, and plays a crucial role in understanding complex biological systems. These services support disease diagnosis, biomarker discovery, and precision treatment development. The increasing demand for personalized medicine, advancements in high-throughput sequencing, and rising use of omics in sectors such as drug discovery, agriculture, and environmental sciences are propelling market growth. As technologies evolve, omics lab services continue to expand their applications and influence in modern science and healthcare.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 72.51 Billion
Market Size 2030USD 124.61 Billion
CAGR 2025-20309.44%
Fastest Growing SegmentCancer
Largest MarketNorth America

Key Market Drivers

Growing Integration Of Genomics Data Into Clinical Workflows

The integration of genomics data into clinical workflows is transforming healthcare and driving significant growth in the Omics Lab Services Market. Genomic insights are reshaping disease diagnosis, risk assessment, and personalized treatment approaches. With increasing accessibility and affordability of genomic data, healthcare providers can now identify patient-specific genetic mutations and susceptibilities, allowing for more targeted and effective interventions. Technologies like high-throughput sequencing and advanced bioinformatics are streamlining the analysis and interpretation of complex datasets, making genomics integration into everyday clinical practices both feasible and beneficial. Omics service providers play a vital role in enabling this transition, delivering the analytical capabilities and expertise required to support precision medicine initiatives.

Key Market Challenges

Lack Of Skilled Professionals

A major challenge facing the Omics Lab Services Market is the shortage of skilled professionals capable of managing and interpreting complex omics data. The sector requires expertise across molecular biology, bioinformatics, and data analytics-fields where highly trained personnel are in short supply. Particularly in bioinformatics, the volume and complexity of data generated by omics platforms necessitate specialized skills in data mining, coding, and statistical analysis. This talent gap leads to data processing delays and limits the scalability of omics services. Furthermore, effective collaboration across interdisciplinary teams is essential, and the lack of professionals capable of bridging these domains impedes broader adoption and integration of omics into healthcare and research.

Key Market Trends

Personalized Medicine

Personalized medicine is a transformative trend reshaping the Omics Lab Services Market by customizing healthcare to individual genetic and molecular profiles. Omics technologies, particularly genomics and proteomics, enable healthcare providers to uncover disease markers and identify therapeutic targets unique to each patient. This is particularly impactful in oncology, where tumor-specific genetic analysis informs the selection of targeted therapies, improving outcomes and reducing adverse effects. Beyond cancer, personalized medicine is expanding into areas such as cardiology, neurology, and rare genetic disorders. The rise of direct-to-consumer genetic testing is further fueling public interest, empowering individuals to take a proactive approach to their health based on personal genetic insights.

Key Market Players

  • Agilent Technologies, Inc.
  • Q2 Solutions LLC
  • Flomics Biotech
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc
  • Quest Diagnostics Incorporated
  • Phenoswitch Bioscience
  • Spectrus Corporation
  • BEIJING GENOMICS INSTITUTE

Report Scope:

In this report, the Global Omics Lab Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Omics Lab Services Market, By Service:

  • Genomics
  • Proteomics
  • Transcriptomics
  • Metabolomics
  • Epigenetics

Omics Lab Services Market, By Frequency Of Service:

  • One-Off
  • Repeat
  • Continuous

Omics Lab Services Market, By Business:

  • Hospitals
  • Research Institutes
  • Diagnostic Labs

Omics Lab Services Market, By End Use:

  • Cancer
  • Pharmaco
  • Reproductive
  • Other Genetic Disease

Omics Lab Services Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Omics Lab Services Market.

Available Customizations:

Global Omics Lab Services market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Omics Lab Services Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Genomics, Proteomics, Transcriptomics, Metabolomics, Epigenetics)
    • 5.2.2. By Frequency Of Service (One-Off, Repeat, Continuous)
    • 5.2.3. By Business (Hospitals, Research Institutes, Diagnostic Labs)
    • 5.2.4. By End Use (Cancer, Pharmaco, Reproductive, Other Genetic Disease) By Region
    • 5.2.5. By Company (2024)
    • 5.2.6. By Region
  • 5.3. Market Map

6. North America Omics Lab Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Frequency of Service
    • 6.2.3. By Business
    • 6.2.4. By End Use
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Omics Lab Services Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Frequency of Service
        • 6.3.1.2.3. By Business
        • 6.3.1.2.4. By End Use
    • 6.3.2. Canada Omics Lab Services Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Frequency of Service
        • 6.3.2.2.3. By Business
        • 6.3.2.2.4. By End Use
    • 6.3.3. Mexico Omics Lab Services Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Frequency of Service
        • 6.3.3.2.3. By Business
        • 6.3.3.2.4. By End Use

7. Europe Omics Lab Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Frequency of Service
    • 7.2.3. By Business
    • 7.2.4. By End Use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Omics Lab Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Frequency of Service
        • 7.3.1.2.3. By Business
        • 7.3.1.2.4. By End Use
    • 7.3.2. United Kingdom Omics Lab Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Frequency of Service
        • 7.3.2.2.3. By Business
        • 7.3.2.2.4. By End Use
    • 7.3.3. Italy Omics Lab Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Frequency of Service
        • 7.3.3.2.3. By Business
        • 7.3.3.2.4. By End Use
    • 7.3.4. France Omics Lab Services Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Frequency of Service
        • 7.3.4.2.3. By Business
        • 7.3.4.2.4. By End Use
    • 7.3.5. Spain Omics Lab Services Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Frequency of Service
        • 7.3.5.2.3. By Business
        • 7.3.5.2.4. By End Use

8. Asia-Pacific Omics Lab Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Frequency of Service
    • 8.2.3. By Business
    • 8.2.4. By End Use
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Omics Lab Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Frequency of Service
        • 8.3.1.2.3. By Business
        • 8.3.1.2.4. By End Use
    • 8.3.2. India Omics Lab Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Frequency of Service
        • 8.3.2.2.3. By Business
        • 8.3.2.2.4. By End Use
    • 8.3.3. Japan Omics Lab Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Frequency of Service
        • 8.3.3.2.3. By Business
        • 8.3.3.2.4. By End Use
    • 8.3.4. South Omics Lab Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Frequency of Service
        • 8.3.4.2.3. By Business
        • 8.3.4.2.4. By End Use
    • 8.3.5. Australia Omics Lab Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Frequency of Service
        • 8.3.5.2.3. By Business
        • 8.3.5.2.4. By End Use

9. South America Omics Lab Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Frequency of Service
    • 9.2.3. By Business
    • 9.2.4. By End Use
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Omics Lab Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Frequency of Service
        • 9.3.1.2.3. By Business
        • 9.3.1.2.4. By End Use
    • 9.3.2. Argentina Omics Lab Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Frequency of Service
        • 9.3.2.2.3. By Business
        • 9.3.2.2.4. By End Use
    • 9.3.3. Colombia Omics Lab Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Frequency of Service
        • 9.3.3.2.3. By Business
        • 9.3.3.2.4. By End Use

10. Middle East and Africa Omics Lab Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service
    • 10.2.2. By Frequency of Service
    • 10.2.3. By Business
    • 10.2.4. By End Use
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Omics Lab Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Frequency of Service
        • 10.3.1.2.3. By Business
        • 10.3.1.2.4. By End Use
    • 10.3.2. Saudi Arabia Omics Lab Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Frequency of Service
        • 10.3.2.2.3. By Business
        • 10.3.2.2.4. By End Use
    • 10.3.3. UAE Omics Lab Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Frequency of Service
        • 10.3.3.2.3. By Business
        • 10.3.3.2.4. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products/Services

14. Competitive Landscape

  • 14.1. Agilent Technologies, Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Q2 Solutions LLC
  • 14.3. Flomics Biotech
  • 14.4. QIAGEN N.V.
  • 14.5. Thermo Fisher Scientific Inc.
  • 14.6. Illumina, Inc
  • 14.7. Quest Diagnostics Incorporated
  • 14.8. Phenoswitch Bioscience
  • 14.9. Spectrus Corporation
  • 14.10. BEIJING GENOMICS INSTITUTE.

15. Strategic Recommendations

16. About Us & Disclaimer